Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China

Clinical Infectious Diseases

Volumn 55, Issue 9, 2012, Pages 1179-1187

  Yang, Chongguang ^a   Luo, Tao ^a   Sun, Guomei ^a   Qiao, Ke ^a   Sun, Gang ^a   Deriemer, Kathryn ^b   Mei, Jian ^c   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHINA; FEMALE; GENE LOCUS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84867510931     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis670     Document Type: Article

References (40)

1. World Health Organization (WHO). Global tuberculosis control: epidemiology, strategy, financing: WHO Report 2009 WHO/HTM/TB/2009411, 2010.
2. China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet 2004; 364(9432):417-22.
3. van Soolingen D, Qian L, de Haas PE, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995; 33:3234-8.
4. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002; 10:45-52. (Pubitemid 34075264)
5. Grode L, Seiler P, Baumann S, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette- Guerin mutants that secrete listeriolysin. J Clin Invest 2005; 115:2472-9. (Pubitemid 41266209)
6. Lopez B, Aguilar D, Orozco H, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003; 133:30-7. (Pubitemid 36791939)
7. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6:302-5. (Pubitemid 30396388)
8. Ebrahimi-Rad M, Bifani P, Martin C, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2003; 9:838-45. (Pubitemid 36801585)
9. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis RIVM. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12:736-43.
10. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005; 293:2726-31. (Pubitemid 40965084)
11. Johnson R, Warren R, Strauss OJ, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis 2006; 10:1412-4. (Pubitemid 44924598)
12. van Rie A, Warren RM, Beyers N, et al. Transmission of a multidrugresistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis 1999; 180:1608-15. (Pubitemid 29506465)
13. Sun YJ, Lim TK, Ong AK, Ho BC, Seah GT, Paton NI. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect Dis 2006; 6:105.
14. Buu TN, Huyen MN, van Soolingen D, et al. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clin Infect Dis 2010; 51:879-86.
15. Parwati I, Alisjahbana B, Apriani L, et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis 2010; 201:553-7.
16. Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb) 2004; 84:337-40. (Pubitemid 38858120)
17. Kremer K, van-der-Werf MJ, Au BK, et al. Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerg Infect Dis 2009; 15:335-9.
18. Mokrousov I, Jiao WW, Sun GZ, et al. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob Agents Chemother 2006; 50:2820-3. (Pubitemid 44198706)
19. Iwamoto T, Yoshida S, Suzuki K, Wada T. Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob Agents Chemother 2008; 52:3805-9.
20. Mestre O, Luo T, Dos Vultos T, et al. Phylogeny of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms in genes involved in DNA replication, recombination and repair. PLoS One 2010; 6:e16020.
21. Filliol I, Motiwala AS, Cavatore M, et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006; 188:759-72. (Pubitemid 43100562)
22. Mokrousov I, Narvskaya O, Otten T, et al. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res Microbiol 2002; 153:629-37. (Pubitemid 35449266)
23. Mokrousov I, Ly HM, Otten T, et al. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res 2005; 15:1357-64. (Pubitemid 41400901)
24. Hanekom M, van der Spuy GD, Streicher E, et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol 2007; 45:1483-90. (Pubitemid 46762402)
25. Hanekom M, van der Spuy GD, Gey van Pittius NC, et al. Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependent. J Clin Microbiol 2007; 45:2263-6. (Pubitemid 47203803)
26. Chang JR, Lin CH, Tsai SF, et al. Genotypic analysis of genes associated with transmission and drug resistance in the Beijing lineage of Mycobacterium tuberculosis. Clin Microbiol Infect 2010; 17:1391-6.
27. World Health Organization. Anti-tuberculosis drug resistance in the world: third global report. Geneva, Switzerland: WHO, 2004; WHO/HTM/TB/2004.343.
28. Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, Gao Q. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007; 87: 446-9. (Pubitemid 47314356)
29. Luo T, Jiang L, Sun W, Fu G, Mei J, Gao Q. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. J Clin Microbiol 2011; 49:3132-8.
30. Zhang L, Chen J, Shen X, et al. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett 2008; 282:22-31. (Pubitemid 351473552)
31. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330:1703-9.
32. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 2010; 10: 103-11.
33. Wada T, Fujihara S, Shimouchi A, et al. High transmissibility of the modern Beijing Mycobacterium tuberculosis in homeless patients of Japan. Tuberculosis (Edinb) 2009; 89:252-5.
34. Kang HY, Wada T, Iwamoto T, et al. Phylogeographical particularity of the Mycobacterium tuberculosis Beijing family in South Korea based on international comparison with surrounding countries. J Med Microbiol 2010; 59(Pt 10):1191-7.
35. Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 2011; 7:e1001307.
36. Brown T, Nikolayevskyy V, Velji P, Drobniewski F. Associations between Mycobacterium tuberculosis strains and phenotypes. Emerg Infect Dis 2010; 16:272-80.
37. Pfyffer GE, Strassle A, van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001; 7: 855-61.
38. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 2005; 40:881-6. (Pubitemid 40365511)
39. Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J Clin Microbiol 2010; 48:3544-50.
40. Werngren J, Hoffner SE. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol 2003; 41: 1520-4. (Pubitemid 36428098)